A defining characteristic of ASPS is the presence of a specific genetic abnormality—the ASPSCR1–TFE3 gene fusion—which results from a translocation between chromosomes X and 17.[8,11] This fusion gene promotes the growth and survival of cancer cells, leading to the development of ASPS. The gene discussed is ASPSCR1; the disease is alveolar soft part sarcoma.